AUSTIN, Texas, June 4, 2019 /PRNewswire/ — The Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is opening a new, state-of-the-art Electrophysiology Center dedicated to treating patients with cardiac arrhythmias. The new Electrophysiology Center is set to open at the end of the month. “This expansion at the Texas Cardiac Arrhythmia Institute […]
Other News
Getinge Opens New Acute Care Section in the Experience Center in Germany
GETINGE, Sweden, June 5, 2019 /PRNewswire/ — Getinge has opened up a brand new acute care section focused on Cardiovascular Procedures in one of its Experience Centers located in Rastatt, Germany. Here, customers have the possibility to learn more about the solutions that Getinge provides to not only aid in the Coronary Artery Bypass Surgery […]
Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders and Provides Update on Neovasc Reducer™
VANCOUVER, June 4, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on June 4, 2019 in Vancouver, B.C. (the “Meeting”). At the Meeting, the shareholders of the Company (the “Shareholders”) re-elected […]
touchCARDIO Joins Forces with Arrhythmia Alliance
LONDON, June 5, 2019 /PRNewswire/ — This World Heart Rhythm Week (3-9 June 2019) Arrhythmia Alliance has announced a collaboration with touchCARDIO that will see the two join forces to further improve the diagnosis, treatment and quality of life for all those affected by arrhythmias. Arrhythmia Alliance World Heart Rhythm Week is an […]
NHS England to Extend Reimbursement for the HeartFlow Analysis Through Innovation and Technology Payment (ITP) Program
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that NHS England has extended HeartFlow’s participation in the Innovation and Technology Payment (ITP) program for an additional year. As part of the extension, NHS England will provide reimbursement to NHS hospitals for the usage of the HeartFlow FFRct Analysis, a non-invasive cardiac test for stable […]
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019
MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Annual Transcatheter Valve Therapy Structural Heart Summit (TVT 2019), which will take place June 12-15 at the Sheraton Grand Chicago. The company’s Tempo® Temporary Pacing Lead will be featured in […]
Silk Road Medical Announces Key TCAR Presentations at the Society for Vascular Surgery 2019 Vascular Annual Meeting
Results Include Data from SVS TCAR Surveillance Project and ROADSTER-2 Study SUNNYVALE, Calif. – June 4, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study […]
Itamar Medical and BioTel Heart, a Division of BioTelemetry, Expand Collaboration to Offer Itamar’s Total Sleep Solution™ to BioTel Heart Cardiology Customers
CAESAREA, Israel, June 04, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea with a focus on the cardiology market, and BioTel Heart, a division of BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused […]
Edwards Lifesciences Recommends Stockholders Reject “Mini-Tender Offer” By TRC Capital Corporation
IRVINE, Calif., June 3, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received notice of an unsolicited “mini-tender offer” by TRC Capital Corporation to purchase up to 1,000,000 shares, or approximately 0.48 percent of the […]
FLEX Vessel Prep™ System Data Presented at New Cardiovascular Horizons Conference Shows Key Findings including Luminal Gain
TOLEDO, Ohio, June 4, 2019 /PRNewswire/ — VentureMed Group, Inc., a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced new data presented at the 20th Annual New Cardiovascular Horizons (NCVH) Annual Conference, May 29-31, in New Orleans, Louisiana. FLEX iDissection Study Results Presentation The study […]



